These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 33151638)

  • 1. Base Editing in Human Cells to Produce Single-Nucleotide-Variant Clonal Cell Lines.
    Vasquez CA; Cowan QT; Komor AC
    Curr Protoc Mol Biol; 2020 Dec; 133(1):e129. PubMed ID: 33151638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Robust Protocol for CRISPR-Cas9 Gene Editing in Human Suspension Cell Lines.
    Wardyn JD; Chan ASY; Jeyasekharan AD
    Curr Protoc; 2021 Nov; 1(11):e286. PubMed ID: 34748280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient Cas9-based Genome Editing Using CRISPR Analysis Webtools in Severe Early-onset-obesity Patient-derived iPSCs.
    Patel A; Iannello G; Diaz AG; Sirabella D; Thaker V; Corneo B
    Curr Protoc; 2022 Aug; 2(8):e519. PubMed ID: 35950852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineering Mutation Clones in Mammalian Cells with CRISPR/Cas9.
    Huo Z; Tu J; Lee DF; Zhao R
    Methods Mol Biol; 2020; 2108():355-369. PubMed ID: 31939194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basics of genome editing technology and its application in livestock species.
    Petersen B
    Reprod Domest Anim; 2017 Aug; 52 Suppl 3():4-13. PubMed ID: 28815851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR/Cas9: an advanced tool for editing plant genomes.
    Samanta MK; Dey A; Gayen S
    Transgenic Res; 2016 Oct; 25(5):561-73. PubMed ID: 27012546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TALEN- and CRISPR/Cas9-Mediated Gene Editing in Human Pluripotent Stem Cells Using Lipid-Based Transfection.
    Hendriks WT; Jiang X; Daheron L; Cowan CA
    Curr Protoc Stem Cell Biol; 2015 Aug; 34():5B.3.1-5B.3.25. PubMed ID: 26237572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determining the Pathogenicity of a Genomic Variant of Uncertain Significance Using CRISPR/Cas9 and Human-Induced Pluripotent Stem Cells.
    Ma N; Zhang JZ; Itzhaki I; Zhang SL; Chen H; Haddad F; Kitani T; Wilson KD; Tian L; Shrestha R; Wu H; Lam CK; Sayed N; Wu JC
    Circulation; 2018 Dec; 138(23):2666-2681. PubMed ID: 29914921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temperature effect on CRISPR-Cas9 mediated genome editing.
    Xiang G; Zhang X; An C; Cheng C; Wang H
    J Genet Genomics; 2017 Apr; 44(4):199-205. PubMed ID: 28412228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome Editing in Human Cells Using CRISPR/Cas Nucleases.
    Wyvekens N; Tsai SQ; Joung JK
    Curr Protoc Mol Biol; 2015 Oct; 112():31.3.1-31.3.18. PubMed ID: 26423589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene Editing With TALEN and CRISPR/Cas in Rice.
    Bi H; Yang B
    Prog Mol Biol Transl Sci; 2017; 149():81-98. PubMed ID: 28712502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AlleleProfileR: A versatile tool to identify and profile sequence variants in edited genomes.
    Bruyneel AAN; Colas AR; Karakikes I; Mercola M
    PLoS One; 2019; 14(12):e0226694. PubMed ID: 31877162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR/Cas genome editing to optimize pharmacologically active plant natural products.
    Dey A
    Pharmacol Res; 2021 Feb; 164():105359. PubMed ID: 33285226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A beginner's guide to gene editing.
    Harrison PT; Hart S
    Exp Physiol; 2018 Apr; 103(4):439-448. PubMed ID: 29282799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [CRISPR/Cas9 technology in disease research and therapy: a review].
    Shi M; Shen Z; Zhang N; Wang L; Yu C; Yang Z
    Sheng Wu Gong Cheng Xue Bao; 2021 Apr; 37(4):1205-1228. PubMed ID: 33973436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Applications of Alternative Nucleases in the Age of CRISPR/Cas9.
    Guha TK; Edgell DR
    Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29186020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [CRISPR/Cas9-based genome editing systems and the analysis of targeted genome mutations in plants].
    Ma XL; Liu YG
    Yi Chuan; 2016 Feb; 38(2):118-25. PubMed ID: 26907775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-Throughput Genotyping of CRISPR/Cas Edited Cells in 96-Well Plates.
    Nussbaum L; Telenius JM; Hill S; Hirschfeld PP; Suciu MC; ; Downes DJ; Hughes JR
    Methods Protoc; 2018 Aug; 1(3):. PubMed ID: 31164571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Introducing Large Genomic Deletions in Human Pluripotent Stem Cells Using CRISPR-Cas3.
    Hou Z; Hu C; Ke A; Zhang Y
    Curr Protoc; 2022 Feb; 2(2):e361. PubMed ID: 35129865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.